So it will absolutely take larger studies to know whether reduced dosing can be a viable approach for the average GLP-1 user
J Neurochem 114:820831 Shinohara M, Saitoh M, Takanashi J, Yamanouchi H, Kubota M, Goto T, Kikuchi M, Shiihara T, Yamanaka G, Mizuguchi M (2011) Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases
While there is no established link between GLP-1 medications and such conditions, new severe headaches always require thorough assessment
India: proposing a health tax and warning labels
This multi-target approach addresses hair loss from multiple angles simultaneously
Your provider may also recommend mental health support, hydration, and nutrition strategies to ease the transition